Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances
Open Access
- 20 June 2026
- journal article
- Published by Elsevier in Military Medical Research
- Vol. 13 (1)
Abstract
No abstract availableKeywords
Funding Information
- Central South University (2022LNJJ10)
- Xiangya Hospital, Central South University
- Department of Science and Technology of Hubei Province (CXPJJH121005-01)
This publication has 819 references indexed in Scilit:
- Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR VariantJAMA, 2024
- Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent GlioblastomaJAMA Network Open, 2023
- Glioblastoma and Other Primary Brain Malignancies in AdultsJAMA, 2023
- Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non–Small Cell Lung Cancer in Patients With Brain MetastasesJAMA Network Open, 2023
- Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade GliomasJAMA Network Open, 2023
- Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain MetastasisJAMA Oncology, 2022
- Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent GlioblastomaJAMA Oncology, 2022
- Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain MetastasesJAMA Oncology, 2022
- Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung CancerJAMA Oncology, 2021
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent GlioblastomaJAMA Oncology, 2020